What is CMI?
CMI, Inc. is a leading entity in the production of breath alcohol testing devices, widely recognized for its Intoxilyzer brand. The company's advanced infrared spectrometry technology is utilized by law enforcement agencies, military organizations, educational institutions, and various commercial sectors. Offering a comprehensive suite of products, including handheld and desktop breath testers, calibration supplies, and training programs, CMI has leveraged over three decades of experience to build a reputation for accuracy and reliability in alcohol detection. As a wholly-owned subsidiary of MPD, Inc., CMI is dedicated to fulfilling global demand for sophisticated breath alcohol testing solutions.
How much funding has CMI raised?
CMI has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in CMI
PPP
Public-Private Partnership
What's next for CMI?
The substantial late-stage funding CMI has attracted, particularly the recent major strategic investment, signals a phase of accelerated expansion and potential market consolidation. This capital infusion is likely to fuel advancements in product development, enhance manufacturing capabilities, and broaden the company's market reach, especially within its core law enforcement and industrial client segments. CMI's strategic positioning, bolstered by this financing, prepares it for continued leadership in the critical field of alcohol detection technology.
See full CMI company page
